The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.
The federal government has allocated $1.15 billion to long-covid research without any new treatments yet brought to market. Patients and scientists say it’s time to push harder for breakthroughs.
A team of researchers led by Emory's Chunhui Xu recently found that heart muscle cells can grow and survive in the ...
In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.
Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...
The study found that 30% of heart failure patients are under the age of 45, and 60% of those patients also suffer from diabetes.
More than 9,000 heart failure patients are expected to get better support in the next five years to live with their condition ...
People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular ...
Background: Heart failure is a complex and multifactorial disease that affects millions globally, posing significant challenges to healthcare systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback